Iran's Oil Windfall and the Quiet Bargain Washington Is Willing to Make

Three of the world's busiest aviation hubs are constrained at once, and the cascading effects will reach far beyond delayed flights.

Blue Owl pulled its funding from UK bridging lender Century Capital after finding irregularities. Now its founder wants to start over.

Stephen Smith's 27% stake in The Economist is more than a media deal. It's a signal about who controls trusted information and why.

While Tesla's Optimus still performs staged demos, Renault has quietly put 350 humanoid robots to work on the factory floor — and the ripple effects go far beyond one plant.

A study of 28 million older Americans finds air pollution may raise Alzheimer's risk by acting directly on the brain, not just through heart disease.

A new human study found that fat-derived molecules called epoxy-oxylipins act as the body's natural brake on inflammation, and a drug that boosts them works.

A study of 3,800 older Americans found the shingles vaccine slows biological aging markers — and it may be interrupting one of the body's key aging feedback loops.

Subtle drops in brain blood flow may signal Alzheimer's risk before plaques appear, and simple scans could one day catch it early.